FIGO STAGE III OVARIAN CANCER 2014
Clinical trials for FIGO STAGE III OVARIAN CANCER 2014 explained in plain language.
Never miss a new study
Get alerted when new FIGO STAGE III OVARIAN CANCER 2014 trials appear
Sign up with your email to follow new studies for FIGO STAGE III OVARIAN CANCER 2014, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Shorter treatment may be just as effective for ovarian cancer patients
Disease control Recruiting nowThis study looks at whether taking the drug olaparib for one year is as good as taking it for two years to keep ovarian cancer from coming back. It includes people with advanced ovarian cancer who have certain gene changes (BRCA or HRD). The goal is to find the best treatment len…
Matched conditions: FIGO STAGE III OVARIAN CANCER 2014
Phase: PHASE3 • Sponsor: NRG Oncology • Aim: Disease control
Last updated May 19, 2026 11:59 UTC
-
New vaccine aims to keep ovarian cancer at bay
Disease control Recruiting nowThis study tests a vaccine made from a patient's own white blood cells, designed to train the immune system to attack ovarian cancer cells. It is for people with advanced stage III or IV ovarian, fallopian tube, or primary peritoneal cancer. The goal is to see if the vaccine can …
Matched conditions: FIGO STAGE III OVARIAN CANCER 2014
Phase: PHASE2 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated May 11, 2026 20:41 UTC